THC Farmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	2009
Period Ending	May '25 May 12, 2025	Sep '14 Sep 30, 2014	Sep '13 Sep 30, 2013	Sep '12 Sep 30, 2012	Sep '11 Sep 30, 2011	Sep '10 Sep 30, 2010	2009
Market Capitalization	0	10	-	-	-	-	Upgrade
Enterprise Value	-	10	-	-	-	-	Upgrade
Last Close Price	0.01	1.10	-	-	-	-	Upgrade
PS Ratio	12.73	518.27	-	-	-	-	Upgrade
PB Ratio	0.23	-205.45	-	-	-	-	Upgrade
EV/Sales Ratio	-	522.19	-	-	-	-	Upgrade
Debt / Equity Ratio	0.68	-1.62	-3.39	6.33	0.37	0.54	Upgrade
Debt / EBITDA Ratio	-	-	-	-	-	15.94	Upgrade
Debt / FCF Ratio	-	-	-	-	0.83	13.12	Upgrade
Asset Turnover	0.02	0.39	0.43	0.52	0.38	-	Upgrade
Quick Ratio	1.98	0.40	0.72	0.57	2.41	6.65	Upgrade
Current Ratio	1.98	0.40	0.72	0.57	2.41	6.65	Upgrade
Return on Equity (ROE)	-14.87%	-	-	-150.55%	-46.96%	-	Upgrade
Return on Assets (ROA)	-4.96%	-31.00%	-24.38%	-25.02%	-16.32%	-	Upgrade
Return on Capital (ROIC)	-5.04%	-42.22%	-27.45%	-26.50%	-16.70%	-	Upgrade
Return on Capital Employed (ROCE)	-	-	-	-	-	0.50%	Upgrade
Earnings Yield	-30.75%	-0.31%	-	-	-	-	Upgrade
FCF Yield	-	-0.19%	-	-	-	-	Upgrade
Buyback Yield / Dilution	-50.42%	-	-	-	-69.35%	-2.08%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.